Menu Expand
Gastrointestinal Pathology: Common Questions and Diagnostic Dilemmas, An Issue of Surgical Pathology Clinics, E-Book

Gastrointestinal Pathology: Common Questions and Diagnostic Dilemmas, An Issue of Surgical Pathology Clinics, E-Book

Rhonda K. Yantiss

(2017)

Additional Information

Abstract

This issue of Surgical Pathology Clinics, edited by Rhonda K. Yantiss, will focus on Gastrointestinal Pathology: Common Questions and Diagnostic Dilemmas. Topics in this issue include, but are not limited to: Other forms of esophagitis; Diagnosis and management of Barrett-related neoplasia in the modern era; Patterns of gastric injury; Practical approach to the flat duodenal biopsy specimen; Chronic colitis in biopsy samples; Mucosal biopsy following bone marrow transplantation; The many faces of medication-related injury in the GI tract; The differential diagnosis of acute colitis: Clues to a specific diagnosis; Problematic colorectal polyps; Persistent problems in colorectal cancer reporting; Emerging concepts in gastric neoplasia; Immunohistochemistry pitfalls; Molecular testing in the modern era, and Lymphoproliferative diseases of the gut.

Table of Contents

Section Title Page Action Price
Front Cover Cover
Gastrointestinal Pathology: Common Questions and Diagnostic Dilemmas\r i
Copyright\r ii
Contributors iii
CONSULTING EDITOR iii
EDITOR iii
AUTHORS iii
Contents v
Preface v
Other Forms of Esophagitis: It Is Not Gastroesophageal Reflux Disease, So Now What Do I Do? v
Diagnosis and Management of Barrett-Related Neoplasia in the Modern Era v
Patterns of Gastric Injury: Beyond Helicobacter pylori v
Practical Approach to the Flattened Duodenal Biopsy v
Chronic Colitis in Biopsy Samples: Is It Inflammatory Bowel Disease or Something Else? vi
The Differential Diagnosis of Acute Colitis: Clues to a Specific Diagnosis vi
The Many Faces of Medication-Related Injury in the Gastrointestinal Tract vi
Mucosal Biopsy After Bone Marrow Transplantation vi
Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders vii
Problematic Colorectal Polyps: Is It Cancer and What Do I Need to Do About It? vii
Persistent Problems in Colorectal Cancer Reporting vii
Immunohistochemical Pitfalls: Common Mistakes in the Evaluation of Lynch Syndrome vii
Molecular Testing of Colorectal Cancer in the Modern Era: What Are We Doing and Why? viii
Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist viii
SURGICAL PATHOLOGY CLINICS\r ix
FORTHCOMING ISSUES ix
March 2018 ix
June 2018 ix
September 2018 ix
RECENT ISSUES ix
September 2017 ix
June 2017 ix
March 2017 ix
Preface xi
Other Forms of Esophagitis 765
ABSTRACT 765
OVERVIEW 765
EOSINOPHILIC ESOPHAGITIS 765
CLINICAL AND ENDOSCOPIC FEATURES 765
MICROSCOPIC FEATURES AND DIAGNOSIS 766
DIFFERENTIAL DIAGNOSIS 767
PROGNOSIS 767
LYMPHOCYTIC ESOPHAGITIS 768
CLINICAL AND ENDOSCOPIC FEATURES 768
MICROSCOPIC FEATURES AND DIAGNOSIS 768
ASSOCIATIONS AND PROPOSED CAUSES 769
DIFFERENTIAL DIAGNOSIS 769
PROGNOSIS 770
SLOUGHING ESOPHAGITIS (ESOPHAGITIS DISSECANS SUPERFICIALIS) 770
CLINICAL AND ENDOSCOPIC FEATURES 770
MICROSCOPIC FEATURES AND DIAGNOSIS 770
DIFFERENTIAL DIAGNOSIS 771
PROGNOSIS 771
MEDICATION-INDUCED ESOPHAGEAL INJURY 771
CLINICAL AND ENDOSCOPIC FEATURES 771
MICROSCOPIC FEATURES AND DIAGNOSIS 772
PROGNOSIS 772
INFECTIOUS ESOPHAGITIS 773
HERPES ESOPHAGITIS 773
Diagnosis and Management of Barrett-Related Neoplasia in the Modern Era 781
ABSTRACT 781
OVERVIEW 781
CLASSIFICATION OF DYSPLASIA IN BARRETT ESOPHAGUS 782
BARRETT ESOPHAGUS: NEGATIVE FOR DYSPLASIA 783
BARRETT ESOPHAGUS: INDEFINITE FOR DYSPLASIA 783
BARRETT ESOPHAGUS: LOW-GRADE DYSPLASIA 783
BARRETT ESOPHAGUS: HIGH-GRADE DYSPLASIA 784
INTRAMUCOSAL CARCINOMA 785
VARIANT DYSPLASIA PATTERNS 786
ROLE OF IMMUNOLABELING 789
TREATMENT AND POST-TREATMENT CHANGES 790
EVALUATION OF ENDOSCOPIC MUCOSAL RESECTION SPECIMENS 792
FOLLOW-UP OF BARRETT ESOPHAGUS PATIENTS 797
PROGNOSTICATION 798
SUMMARY 799
REFERENCES 799
Patterns of Gastric Injury 801
ABSTRACT 801
OVERVIEW 801
GASTRITIS WITH PROMINENT INFLAMMATORY INFILTRATES IN THE LAMINA PROPRIA 802
GASTRITIS WITH LYMPHOPLASMACYTIC INFLAMMATION 802
Autoimmune Gastritis 802
Syphilitic Gastritis 802
GASTRITIS WITH PROMINENT INFLAMMATION AND SUBEPITHELIAL COLLAGEN DEPOSITION 803
Collagenous Gastritis 803
GASTRITIS WITH PREDOMINANTLY LYMPHOCYTIC INFLAMMATION 806
Epstein-Barr Virus–Associated Gastritis 806
Lymphomatoid Gastropathy (Natural Killer Cell Enteropathy) 806
GASTRITIS WITH INTRAEPITHELIAL LYMPHOCYTOSIS 806
Lymphocytic Gastritis 806
GASTRITIS WITH EOSINOPHIL-RICH INFLAMMATION 806
Eosinophilic Gastritis and Gastroenteritis 806
GASTRITIS WITH PREDOMINANTLY NEUTROPHILIC INFLAMMATION 810
Acute Suppurative (Phlegmonous) Gastritis 810
Emphysematous Gastritis 810
Doxycycline-Induced Gastritis 811
GASTRITIS WITH GRANULOMATOUS INFLAMMATION 811
CROHN'S DISEASE 811
SARCOIDOSIS 811
INFECTIOUS GASTRITIS 812
GASTRITIS WITH LIMITED LAMINA PROPRIA INFLAMMATION 812
GASTRITIS WITH VIRAL INCLUSIONS 812
Cytomegalovirus-Associated Gastritis 812
Herpes Simplex Virus–Associated Gastritis 812
GASTRITIS WITH HEMORRHAGE AND/OR NECROSIS 813
Caustic Gastritis 813
Ulcero-Hemorrhagic Gastritis 813
REACTIVE (CHEMICAL) GASTROPATHY 814
GASTRITIS WITH INCREASED APOPTOSIS AND/OR ATYPICAL MITOTIC FIGURES 816
Graft-Versus-Host Disease 816
Drug-Induced Gastritis Due to Colchicine and Taxol 816
Chemoradiation-Induced Gastritis 817
GASTRITIS CHARACTERIZED BY CRYSTAL OR PIGMENT DEPOSITION 817
IRON PILL GASTRITIS 817
GASTRIC MUCOSAL CALCINOSIS 817
LANTHANUM CARBONATE 820
KAYEXALATE IN SORBITOL 820
REFERENCES 820
Practical Approach to the Flattened Duodenal Biopsy 823
ABSTRACT 823
A SYSTEMATIC APPROACH TO DUODENAL BIOPSIES 823
CELIAC DISEASE: HISTOLOGY, REPORTING, SPECIAL SITUATIONS, DIFFERENTIAL DIAGNOSIS 825
HISTOLOGY 825
SPECIAL SITUATIONS IN CELIAC DISEASE 826
Ultra-short Celiac Disease 826
Collagenous Sprue 826
Treated Celiac Disease 828
Refractory Celiac Disease 829
DIFFERENTIAL DIAGNOSIS 830
Tropical Sprue 830
Common Variable Immunodeficiency 832
Autoimmune Enteropathy 832
Medication Injury 832
Small Intestinal Bacterial Overgrowth 835
Inflammatory Bowel Disease 835
THE PATHOLOGY REPORT 835
REFERENCES 838
Chronic Colitis in Biopsy Samples 841
ABSTRACT 841
OVERVIEW 841
NORMAL COLON HISTOLOGY 842
INFLAMMATORY BOWEL DISEASE 842
ULCERATIVE COLITIS 842
CROHN COLITIS 847
INDETERMINATE COLITIS 853
EFFECT OF TREATMENT ON INFLAMMATORY BOWEL DISEASE 853
DIFFERENTIAL DIAGNOSIS OF CHRONIC COLITIS 853
THE NONDISTORTING, NONULCERATING COLITIDES 855
CHRONIC COLITIDES WITH VARIABLE HISTOLOGIC FEATURES 857
Diverticular Disease–Associated Colitis 857
Diversion Colitis 858
Drug-Associated Chronic Colitis 858
Infection and Unclassified Colitides 859
SUMMARY 860
REFERENCES 861
The Differential Diagnosis of Acute Colitis: Clues to a Specific Diagnosis 863
ABSTRACT 863
OVERVIEW 863
HISTOLOGY OF THE NORMAL COLONIC MUCOSA 864
HISTOLOGIC PATTERNS ASSOCIATED WITH ACUTE COLITIS 864
ACUTE COLITIS (ACUTE SELF-LIMITED COLITIS) 865
HISTOPATHOLOGY 866
DIFFERENTIAL DIAGNOSIS OF ACUTE COLITIS AND INFLAMMATORY BOWEL DISEASE 866
INFECTIOUS CAUSES OF ACUTE COLITIS WITH SPECIAL HISTOLOGIC PATTERNS 868
FOCAL ACTIVE COLITIS 873
HISTOPATHOLOGY 874
ACUTE COLITIS WITH ISCHEMIC FEATURES 874
PSEUDOMEMBRANOUS COLITIS 875
HISTOPATHOLOGY 877
DIFFERENTIAL DIAGNOSIS 877
HEMORRHAGIC COLITIS 877
HISTOPATHOLOGY 878
ACUTE ISCHEMIC COLITIS 878
HISTOPATHOLOGY 882
SUMMARY 883
REFERENCES 883
The Many Faces of Medication-Related Injury in the Gastrointestinal Tract 887
ABSTRACT 887
OVERVIEW 887
CHEMOTHERAPEUTIC AGENTS 888
IMMUNOMODULATORS AND TARGETED AGENTS 889
ANTIBIOTICS 890
BISPHOSPHONATES 892
IRON 893
RESINS 895
SARTANS 896
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 900
IMMUNOSUPRESSIVE AGENTS 902
SUMMARY 906
REFERENCES 906
Mucosal Biopsy After Bone Marrow Transplantation 909
ABSTRACT 909
OVERVIEW 909
GRAFT-VERSUS-HOST DISEASE 910
CLINICAL FEATURES 910
PATHOGENESIS OF GRAFT-VERSUS-HOST DISEASE 910
MORPHOLOGIC FEATURES OF GRAFT-VERSUS-HOST DISEASE 910
GRADING OF GRAFT-VERSUS-HOST DISEASE 911
PATHOLOGIC FEATURES OF CHRONIC GRAFT-VERSUS-HOST DISEASE 913
REPORTING GRAFT-VERSUS-HOST DISEASE 914
DIFFERENTIAL DIAGNOSIS OF GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE 915
CHEMOTHERAPY-INDUCED INJURY 916
MYCOPHENOLATE MOFETIL (CELLCEPT) 916
PROTON PUMP INHIBITOR EFFECT 921
BOWEL PREPARATION 921
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 921
CORD COLITIS 921
INFECTION 922
CYTOMEGALOVIRUS 922
ADENOVIRUS 923
STRONGYLOIDES STERCORALIS 923
IDIOPATHIC ESOPHAGEAL ULCERS 925
NEUTROPENIC ENTEROCOLITIS 925
SUMMARY 927
REFERENCES 927
Emerging Concepts in Gastric Neoplasia 931
ABSTRACT 931
OVERVIEW 931
HEREDITARY DIFFUSE GASTRIC CANCER 932
CDH1 GERMLINE MUTATION 932
CTNNA1 GERMLINE MUTATION 937
OTHER MUTATIONS DESCRIBED IN HEREDITARY DIFFUSE GASTRIC CANCER 937
FAMILIAL INTESTINAL GASTRIC CANCER 937
GASTRIC POLYPOSIS AND GASTRIC CANCER PREDISPOSITION 937
BACKGROUND 937
FUNDIC GLAND POLYPOSIS SYNDROMES 938
GAPPS (Gastric Adenocarcinoma and Proximal Polyposis of the Stomach)-Related Gastric Polyposis and Cancer 938
Familial Adenomatous Polyposis and Gastric Fundic Gland Polyposis 938
MUTYH-Associated Polyposis and Gastric Fundic Gland Polyposis 938
GASTRIC HAMARTOMATOUS POLYPOSIS 938
Peutz-Jeghers Syndrome 938
Juvenile Polyposis 940
Phosphatase and Tensin Homolog Hamartoma Tumor Syndrome (Including Cowden Syndrome) 940
OTHER HEREDITARY CANCER SYNDROMES IN WHICH GASTRIC CANCER RISK IS INCREASED 940
LYNCH SYNDROME AND GASTRIC CANCER RISK 940
LI-FRAUMENI SYNDROME AND GASTRIC CANCER RISK 941
HEREDITARY BREAST AND OVARIAN CANCER AND GASTRIC CANCER RISK 941
SUMMARY 942
REFERENCES 943
Problematic Colorectal Polyps 947
ABSTRACT 947
OVERVIEW 947
EPITHELIAL MISPLACEMENT VERSUS ADENOCARCINOMA 948
MANAGEMENT OF MALIGNANT COLORECTAL POLYPS 955
REFERENCES 959
Persistent Problems in Colorectal Cancer Reporting 961
ABSTRACT 961
OVERVIEW 961
ASSIGNING TUMOR STAGE TO LOCALLY ADVANCED CANCERS 962
DEFINITIONS OF TUMOR STAGE (PT) 962
DEFINITION OF SEROSAL PENETRATION (PT4A) 962
FEATURES OF SEROSAL PENETRATION AT THE TIME OF GROSS EXAMINATION 963
HISTOLOGIC FEATURES OF SEROSAL PENETRATION 963
USE OF ANCILLARY TESTS TO FACILITATE DETECTION OF SEROSAL PENETRATION 966
STAGING REGIONAL LYMPH NODES 966
DEFINITIONS OF LYMPH NODE STAGE (PN) 966
GROSS EXAMINATION OF REGIONAL LYMPH NODES 966
MICROMETASTASES AND ISOLATED TUMOR CELLS 968
ACELLULAR MUCIN IN LYMPH NODES FROM TREATMENT-NAÏVE PATIENTS 969
TUMOR DEPOSITS IN PERICOLORECTAL SOFT TISSUE 970
PROGNOSTIC IMPORTANCE OF RESPONSE TO NEOADJUVANT THERAPY 974
SUMMARY 974
REFERENCES 975
Immunohistochemical Pitfalls 977
ABSTRACT 977
OVERVIEW 977
MISMATCH REPAIR PROTEIN IMMUNOHISTOCHEMISTRY AND MICROSATELLITE INSTABILITY 978
DIAGNOSTIC ALGORITHM FOR SCREENING NEWLY DIAGNOSED COLORECTAL CANCER FOR LYNCH SYNDROME 978
USUAL AND UNUSUAL STAINING PATTERNS OF MISMATCH REPAIR PROTEINS 981
REPORTING AND INTERPRETATION PITFALLS FOR MISMATCH REPAIR PROTEIN IMMUNOHISTOCHEMISTRY 981
MISMATCH REPAIR-DEFICIENT COLORECTAL CANCERS 987
COMMONLY ENCOUNTERED MISTAKES IN INTERPRETING MISMATCH REPAIR PROTEIN EXPRESSION USING IMMUNOHISTOCHEMISTRY 989
SUMMARY 1002
REFERENCES 1004
Molecular Testing of Colorectal Cancer in the Modern Era 1009
ABSTRACT 1009
OVERVIEW 1009
ESTABLISHED BIOMARKERS 1010
MICROSATELLITE INSTABILITY 1010
MLH1 PROMOTER HYPERMETHYLATION 1011
RAS MUTATIONS 1012
BRAF V600E MUTATION 1012
EMERGING BIOMARKERS 1014
PIK3CA MUTATIONS 1014
HER2 GENETIC ALTERATIONS 1014
PRACTICAL CONSIDERATIONS 1015
APPROACHES TO GENOTYPING 1015
TYPE OF SPECIMEN 1015
SUMMARY 1016
REFERENCES 1016
Lymphoproliferative Diseases of the Gut 1021
ABSTRACT 1021
OVERVIEW 1021
GASTROINTESTINAL LYMPHOID TISSUE 1022
SPECIFIC GASTROINTESTINAL LYMPHOMAS 1024
B-CELL LYMPHOMAS 1024
Diffuse Large B-Cell Lymphoma 1024
Mucosa-Associated Lymphoid Tissue Lymphoma 1026
Follicular lymphoma 1028
Mantle Cell Lymphoma 1029
Burkitt Lymphoma 1031
T-CELL LYMPHOMAS 1032
Enteropathy-Associated T-Cell Lymphoma 1032
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type 1033
GENERAL APPROACH TO GASTROINTESTINAL LYMPHOMA DIAGNOSIS 1034
SUMMARY 1036
REFERENCES 1036